Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Collaborate
About
EQOH
Careers
Contact Us
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Filter Content:
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Videos
Diabetes
26 Nov 2015
Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients? Opening Remarks
Prof Ele Ferrannini of the University of Pisa School of Medicine, Pisa, Italy, welcomes congress delegates to a Takeda-sponsored symposium held at the…
Oncology
19 Nov 2015
Genomics England: 100,000 Genomes Project
Clare Turnbull, MD, PhD, gives an overview of her talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference, where the Genomics…
Oncology
19 Nov 2015
Reducing prostate cancer progression and mortality: what patients can do to reduce risk
Stacey Kenfield, DSc gives an overview of her talk at the 2015 National Cancer Research Institute (NCRI) Cancer Conference. Dr Kenfield talks about how…
Oncology
19 Nov 2015
Helping healthcare professionals initiate conversations about physical activity
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Justin Webb talks about the initiatives Macmillan Cancer Support is implementing…
Oncology
19 Nov 2015
Keeping active with Macmillan Cancer Support
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Justin Webb gives an overview of a new Macmillan Cancer Support initiative aimed…
Oncology
19 Nov 2015
Physical activity – the panacea?
Robert Thomas, MbChb, MRCP, MD, FRCR, gives an overview of the session “Physical activity – the panacea?” at the 2015 National Cancer Research Institute…
Oncology
19 Nov 2015
The development of genomic tests and how validation affects their use in the clinic
At the 2015 American Society of Clinical Oncology (ASCO) Annual Meeting, Giampaolo Bianchini, MD, of the San Raffaele Scientific Institute, Milan, Italy…
Oncology
19 Nov 2015
2015 NCRI Cancer Conference: Francis Crick Institute scientists
Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, discusses topics covered…
Oncology
19 Nov 2015
Clonal evolution in colorectal cancer
At the 2015 National Cancer Research Institute (NCRI) Cancer Conference, Alberto Bardelli, PhD talks about clonal evolution in colorectal cancer. He also…
Oncology
19 Nov 2015
Update on CheckMate 067, an advanced melanoma clinical trial
James Larkin, MD, PhD gives an update on the clinical trial CheckMate 067, a phase 3 study of Nivolumab or Nivolumab plus Ipilimumab versus Ipilimumab…
Oncology
19 Nov 2015
Physical activity levels and barriers to exercise referral among patients with cancer
Dorothy Yang gives an overview of a study assessing the physical activity levels and barriers to exercise referral among patients with cancer, at the…
Oncology
19 Nov 2015
2015 NCRI Cancer Conference: Featured sessions
Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, gives an overview of the…
Oncology
19 Nov 2015
2015 NCRI Cancer Conference: The highlights
Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research Institute, London, UK, gives an overview of the…
Oncology
19 Nov 2015
Current status and future prospective of Trial Assigning IndividuaLized Options for Treatment (Rx)
At the European Cancer Congress (ECC) 2015, André Robidoux, MD, FRCSC, of Centre Hospitalier de l’Université de Montréal, Montreal, Canada, discusses…
Oncology
23 Oct 2015
Results and impact of TAILORx: Trial Assigning IndividuaLized Options for Treatment (Rx)
At the European Cancer Congress (ECC) 2015, André Robidoux, MD, FRCSC, of Centre Hospitalier de l’Université de Montréal, Montreal, Canada, discusses…
Oncology
23 Oct 2015
Immunotherapy: Targeting tumour heterogeneity
At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research…
Oncology
15 Oct 2015
New approaches to molecular cancer therapeutics
At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research…
Oncology
15 Oct 2015
The Patient Reported Opinions about Clinical Tolerability (PROACT)
At the European Cancer Congress (ECC) 2015, Hendrik-Tobias Arkenau, MD, PhD, of Sarah Cannon Research Institute UK, London, UK, discusses Patient…
Oncology
15 Oct 2015
EURECCA international comparison of treatment patterns for non-metastatic breast cancer
At the European Cancer Congress (ECC) 2015, Riccardo A. Audisio, MD, FRCS, of the University of Liverpool, St. Helens Teaching Hospital, St. Helens, UK…
Oncology
15 Oct 2015
Results from the ETOP Lungscape Project: Multiplex mutation testing in NSCLC
At the European Cancer Congress (ECC) 2015, Keith M. Kerr, BSc, MB, ChB, FRCPath, FRCPE, of the University of Aberdeen, Aberdeen, Scotland, discusses the…
Oncology
15 Oct 2015
The causes and consequences of tumour evolution and heterogeneity
At the European Cancer Congress (ECC) 2015, Charles Swanton, FRCP, BSc, PhD, of The Francis Crick Institute and Cancer Research UK London Research…
Oncology
15 Oct 2015
Patient-centered partnership improve access to optimal standards of cancer care in Europe
European Cancer Patient Coalition (ECPC) is the largest European cancer patients’ umbrella organisation, representing 365 patient organisations in 40…
Oncology
15 Oct 2015
ECC 2015: Press programme with updates on ‘Europe of Disparities in Cancer’
At the European Cancer Congress (ECC) 2015, Mark Lawler, PhD, of Queen’s University Belfast, Belfast, UK, Richard Sullivan, MD, PhD, of King’s College…
Oncology
15 Oct 2015
The discovery of new biomarkers for predicting outcomes in breast cancer
In patients with early stage breast cancer, there is a need to identify prognostic factors to determine the risk of recurrence and predictive factors to…
Loading posts...
« Previous
1
…
71
72
73
74
75
…
98
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View